Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome.
about
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profilingAdenoid cystic carcinoma: clinical and molecular features.Fusion oncogenes in salivary gland tumors: molecular and clinical consequencesMicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome.A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets.Differences in MYB expression and gene abnormalities further confirm that salivary cribriform basal cell tumors and adenoid cystic carcinoma are two distinct tumor entities.MYB rearrangement and clinicopathologic characteristics in head and neck adenoid cystic carcinoma.Development and characterization of salivary adenoid cystic carcinoma cell line.MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2.Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) TranslocationsIdentification of methylated genes in salivary gland adenoid cystic carcinoma xenografts using global demethylation and methylation microarray screeningAdenoid cystic carcinoma: emerging role of translocations and gene fusionsWhole exome sequencing of adenoid cystic carcinoma.Salivary gland carcinomas.Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker.Genetic alterations in salivary gland cancers.Genetic Characterization of Adenoid Cystic Carcinoma of the Minor Salivary Glands: A Potential Familial Occurrence in First-Degree Relatives.Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer.Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 casesMYB immunostaining is a useful ancillary test for distinguishing adenoid cystic carcinoma from pleomorphic adenoma in fine-needle aspiration biopsy specimens.Thymic Tumor With Adenoid Cystic Carcinoma-Like Features: A Study of a Clinically Favorable Case Followed for 9 Years.Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.Analysis of MYB oncogene in transformed adenoid cystic carcinomas reveals distinct pathways of tumor progression.Prunella vulgaris Attenuates Diabetic Renal Injury by Suppressing Glomerular Fibrosis and Inflammation.Clinical and molecular insights into adenoid cystic carcinoma: Neural crest‐like stemness as a target.Clinical and molecular insights into adenoid cystic carcinoma: Neural crest-like stemness as a target.MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.Spatio-Temporal Genomic Heterogeneity, Phylogeny, and Metastatic Evolution in Salivary Adenoid Cystic Carcinoma.Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.MYB Translocation Status in Salivary Gland Epithelial-Myoepithelial Carcinoma: Evaluation of Classic, Variant, and Hybrid Forms.Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making.Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes.Morphologically low-grade spiradenocarcinoma: a clinicopathologic study of 19 cases with emphasis on outcome and MYB expression.Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma.Genomics of mucoepidermoid and adenoid cystic carcinomas.
P2860
Q26781643-E815CCFB-C3CD-41EF-86F3-7D106391D6D6Q26996614-33465157-BCC9-4230-9380-9B2742BEE28AQ27000115-D019FAB7-470C-4660-96F2-28F6B2035DA6Q34794257-513CC138-8541-4AF5-B40F-61D71E42A499Q35149666-804787DF-79F7-4ED6-82F9-782D8680D968Q35880030-6880AEA5-1419-4778-A8D4-FA6B8C7C546DQ35988629-82B1439C-0BBD-4BAC-B415-92C97450756AQ36069693-30254852-F6E8-4F5F-A3CD-DCE26C72562CQ36500392-C519B3F5-7406-4F02-97B7-0E1321645A11Q36726987-BFA9B3D6-642B-4E37-A2ED-5E3FB9E30515Q36992178-3DEA5E8F-7811-4AE0-8CB3-1333C2F44FF6Q37662396-E6DDD1E4-9AEC-43A2-B100-DD4643A9D418Q37722072-074D21AA-8B53-4734-B59C-6EDD492FBEAFQ38030395-653E28BA-B442-487E-B207-6235077FDDDDQ38275143-75CBA41F-E6E2-48C7-9363-11E2D4497673Q38376366-7DEEBB7A-FC42-4D5E-8749-622043FA9DE0Q38492040-4A6E6FD9-0F64-4777-A911-1AF9A9D44C2EQ38755879-62937E4E-8175-490A-9C74-6B799B656F3EQ38955838-E5243C10-3D97-4806-9EFE-271C4F198951Q39360520-C9A74303-600E-4F46-B5A8-21D22D010735Q40765189-CD4F0871-0AA4-4063-A48F-91303C59571FQ41835934-CB42229C-0C34-4D99-84BC-AF18550E0F51Q42251330-A9900164-1248-4620-BEEC-DB6454CFF1C6Q42480003-6D411AF7-9B08-4AAA-AD0B-D85A5468AAC8Q44007964-26A8991F-BA19-4D31-876A-0EA9E1BF7179Q46177328-049A8B49-7C96-483C-ABB5-3EDB6C3F1B69Q46393740-72B011C2-B466-4B3E-9BF4-B3761D82ACE2Q46831652-6F67C1AF-49CF-45E1-81CA-1A505EF4A561Q47999487-3A6508BD-C8C3-4C0C-AB12-EBDF6D013684Q48307548-90E82306-77F4-4BB9-ADDE-C24FF3983AECQ48607061-8E63ABE3-14B7-4CFB-943F-0752259B22DEQ49832806-438FD868-49E2-42A4-9F9D-09FEB9F32D05Q50030418-8DE04DE9-266E-4DA5-AFB4-2D7EBB581332Q52611827-D33DB7A8-CC21-429D-80DE-280EA9BE0834Q52684155-2FD725C2-3EDE-422A-81F9-BC4FEDA6F5B9Q53170129-CE75A873-4AFD-423E-903B-2C0820741362Q54314557-0BA84C26-BDE2-4C41-BB9D-EB6DEB6BDC39Q54963200-B5464D60-0DB6-4F7C-B003-A380F688749B
P2860
Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Novel chromosomal rearrangemen ...... ression, and clinical outcome.
@ast
Novel chromosomal rearrangemen ...... ression, and clinical outcome.
@en
type
label
Novel chromosomal rearrangemen ...... ression, and clinical outcome.
@ast
Novel chromosomal rearrangemen ...... ression, and clinical outcome.
@en
prefLabel
Novel chromosomal rearrangemen ...... ression, and clinical outcome.
@ast
Novel chromosomal rearrangemen ...... ression, and clinical outcome.
@en
P2093
P2860
P1476
Novel chromosomal rearrangemen ...... ression, and clinical outcome.
@en
P2093
Adel K El-Naggar
Carlos Caulin
Dianna B Roberts
Mutsumi Mitani
Philip J Stephens
Pulivarthi H Rao
Randal S Weber
Scott M Lippman
Yi-Jue Zhao
P2860
P304
P356
10.1158/1078-0432.CCR-11-1870
P407
P577
2011-10-05T00:00:00Z